NCT06164275
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06164275
Title Pembrolizumab Followed by Chemotherapy for the Treatment of Patients With Classical Hodgkin Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Northwestern University
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Stanford Cancer Center Stanford California 94305-5824 United States Details
Northwestern University Chicago Illinois 60611 United States Details
Northwestern Delnor IL258 Geneva Illinois 60134 United States Details
Cadence Health - CDH Warrenville Illinois 60555 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field